The corporate battle between Zandu Pharmaceutical Works and Emami has now shifted to the Company Law Board (CLB).
In its order dated August 7, the Bombay High Court directed CLB to decide on Zandu’s application, a notice issued by Zandu today to the Bombay Stock Exchange said.
Zandu had approached the Bombay High Court, asking CLB to look into its allegations of a breach of the takeover code and non-compliance with the MRTP laws.
The promoters of Mumbai-based Zandu had also challanged the Vaidya family’s 24 per cent stake sale to Emami and said they had the first right of refusal. Emami too had petitioned to the Zandu promoters, complaining that they had not received the agenda of the company’s scheduled annual general meeting.
Zandu has challenged the acquisition of the company’s shares from the Vaidyas on grounds that it is a gross violation of variuos laws such as the Takeover Regulations, 1997, the Sebi Insider Trading Regulations, 1992, and the Companies Act, 1956.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
